3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
SCLC, Extensive Stage
1
Prostatic Neoplasms
1
Glioblastoma
1
Fludzoparib" and Anti-angiogenic
1
Advanced Solid Tumors
1
Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer
1
Interventions
Cisplatin
24
Paclitaxel
21
pembrolizumab
15
Radiotherapy
12
Fluorouracil
12
Carboplatin
12
Drug Therapy
11
tislelizumab
10
toripalimab
9
Irinotecan
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Radiation
5
Neoadjuvant Therapy
5
Leucovorin
5
lenvatinib
4
camrelizumab
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Docetaxel
4
130-nm albumin-bound paclitaxel
4
apatinib
3
Taxes
3
Itraconazole
3
Injections
3
Albumin-Bound Paclitaxel
3
spartalizumab
2
sintilimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
fluzoparib
×
1 year
×
Clear all
No trials found.